Drugs / PXT012253
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03826134 | Jan → Mar 2019 | Parkinson disease | H. Lundbeck A/S | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PXT012253 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03826134 ↗ |
| Route | Intravenous | “Single intravenous bolus injection” NCT03826134 ↗ |